-Reuters Abbott Laboratories Inc has instructed its sales representatives in India not to give gifts to doctors, a practice that has been used as a bargaining chip by companies wanting a piece of the country’s burgeoning healthcare market. According to an internal email dated October 11 from Sudarshan Jain, managing director of Abbott Healthcare Pvt. Ltd, the gift-giving has been temporarily suspended. “Only Abbott-approved clinical/scientific literature may be distributed to current and potential...

-Live Mint The OECD forum is discussing how to make the aspirations of the common man relevant to policymaking New Delhi: In the face of a deepening economic crisis and social resistance to austerity measures, world leaders are considering a collective experiment to include parameters such as well-being and happiness in national and international statistics. The Organisation for Economic Co-operation and Development’s (OECD) World Forum on Measuring Well-being for Development Policy Making being...

-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...

-Live Mint Incidents at Bhopal and Indore highlight irregularities and ethical violations in some trials In 2004, doctors at the Bhopal Memorial Hospital and Research Centre (BMHRC), established exclusively for treating the victims of the 1984 gas leak, recruited unsuspecting survivors for clinical trials without their knowledge or consent; 14 participants died during the course of the trials. Together with the episode in Indore’s Maharaja Yashwantrao Hospital (that Mint reported on 10...

-Live Mint The first in a two-part series examining the opaque world of clinical trials in India  A hospital in Indore has been able to get away with unethical medical trials in which 32 people have died over five years, according to the state government. This despite several investigations, a state government ban and Supreme Court strictures—a classic example of the lawless nature of the clinical trial business in India.   Lata Mehra, who...